Skip to content
10-Q

Quarterly Report

ARATANA THERAPEUTICS, INC.

0001509190-19-000034

← back to feed
Filed
May 9, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · May 3, 2019 48.97M sh
Operating Cash Flow Q1 2019 · Mar 31, 2019 −$5.49M
Operating Cash Flow Q1 2019 · Mar 31, 2018 −$13.21M
Short Term Investments Q1 2019 · Mar 31, 2019 $496K
Short Term Investments Q1 2019 · Dec 31, 2018 $1.24M
Cash And Equivalents Q1 2019 · Mar 31, 2019 $36.56M
Cash And Equivalents Q1 2019 · Dec 31, 2018 $41.43M
Stockholders Equity Q1 2019 · Mar 31, 2019 $96.22M
Stockholders Equity Q1 2019 · Dec 31, 2018 $100.82M
Stockholders Equity Q1 2019 · Mar 31, 2018 $95.64M
Stockholders Equity Q1 2019 · Dec 31, 2017 $80.13M
Current Liabilities Q1 2019 · Mar 31, 2019 $8.1M
Current Liabilities Q1 2019 · Dec 31, 2018 $5.56M
Total Liabilities Q1 2019 · Mar 31, 2019 $8.49M
Total Liabilities Q1 2019 · Dec 31, 2018 $5.61M
Current Assets Q1 2019 · Mar 31, 2019 $53.92M
Current Assets Q1 2019 · Dec 31, 2018 $58.13M
Total Assets Q1 2019 · Mar 31, 2019 $104.71M
Total Assets Q1 2019 · Dec 31, 2018 $106.44M
Sga Expense Q1 2019 · Mar 31, 2019 $9.19M
Sga Expense Q1 2019 · Mar 31, 2018 $7.7M
Net Income Q1 2019 · Mar 31, 2019 −$6.79M
Net Income Q1 2019 · Mar 31, 2018 −$8.55M
Operating Income Q1 2019 · Mar 31, 2019 −$6.96M
Operating Income Q1 2019 · Mar 31, 2018 −$7.83M
Cost Of Revenue Q1 2019 · Mar 31, 2019 $1.52M
Cost Of Revenue Q1 2019 · Mar 31, 2018 $536K
Revenue Q1 2019 · Mar 31, 2019 $7.36M
Revenue Q1 2019 · Mar 31, 2018 $4.04M